Literature DB >> 19154989

Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor.

Jianghuai Liu1, Wei-Chun HuangFu, K G Suresh Kumar, Juan Qian, James P Casey, Robert B Hamanaka, Christina Grigoriadou, Rafael Aldabe, J Alan Diehl, Serge Y Fuchs.   

Abstract

Phosphorylation-dependent ubiquitination and degradation of the IFNAR1 chain of the type I interferon (IFN) receptor is regulated by two different pathways, one of which is ligand independent. We report that this ligand-independent pathway is activated by inducers of unfolded protein responses (UPR), including viral infection, and that such activation requires the endoplasmic reticulum-resident protein kinase PERK. Upon viral infection, activation of this pathway promotes phosphorylation-dependent ubiquitination and degradation of IFNAR1, specifically inhibiting type I IFN signaling and antiviral defenses. Knockin of an IFNAR1 mutant insensitive to virus-induced turnover or conditional knockout of PERK prevented IFNAR1 degradation, whether UPR-induced or virus-induced, and restored cellular responses to type I IFN and resistance to viruses. These data suggest that specific activation of the PERK component of UPR can favor viral replication. Interfering with PERK-dependent IFNAR1 degradation could therefore contribute to therapeutic strategies against viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154989      PMCID: PMC2741731          DOI: 10.1016/j.chom.2008.11.008

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  54 in total

1.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  Aggregation of embryos and embryonic stem cells.

Authors:  Ronald Maatman; Marina Gertsenstein; Emile de Meijer; Andras Nagy; Kristina Vintersten
Journal:  Methods Mol Biol       Date:  2003

Review 3.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 4.  Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3.

Authors:  Gulam Waris; Keith D Tardif; Aleem Siddiqui
Journal:  Biochem Pharmacol       Date:  2002-11-15       Impact factor: 5.858

5.  The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas.

Authors:  Peichuan Zhang; Barbara McGrath; Sheng'ai Li; Ami Frank; Frank Zambito; Jamie Reinert; Maureen Gannon; Kun Ma; Kelly McNaughton; Douglas R Cavener
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range.

Authors:  Jeffrey O Langland; Bertram L Jacobs
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

7.  IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.

Authors:  Mamta Chawla-Sarkar; Douglas W Leaman; Barbara S Jacobs; Ernest C Borden
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

8.  SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

Authors:  K G Suresh Kumar; Weigang Tang; Abhilash K Ravindranath; William A Clark; Ed Croze; Serge Y Fuchs
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 9.  Cancer immunotherapy: the interferon-alpha experience.

Authors:  John Kirkwood
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

10.  Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).

Authors:  Mamta Chawla-Sarkar; Douglas W Leaman; Barbara S Jacobs; Ralph J Tuthill; Moitreyee Chatterjee-Kishore; George R Stark; Ernest C Borden
Journal:  J Interferon Cytokine Res       Date:  2002-05       Impact factor: 2.607

View more
  84 in total

1.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

2.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

3.  Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis.

Authors:  Hui Zheng; Juan Qian; Christopher J Carbone; N Adrian Leu; Darren P Baker; Serge Y Fuchs
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

4.  Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Audrey Lasri; Ning Li; Daniel P Beiting; Amy C Durham; Ting Yang; Eli Pikarsky; Christopher J Lengner; F Brad Johnson; Yinon Ben-Neriah; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2016-01-25       Impact factor: 4.272

Review 5.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

6.  Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Authors:  Kanstantsin V Katlinski; Jun Gui; Yuliya V Katlinskaya; Angelíca Ortiz; Riddhita Chakraborty; Sabyasachi Bhattacharya; Christopher J Carbone; Daniel P Beiting; Melanie A Girondo; Amy R Peck; Ellen Puré; Priya Chatterji; Anil K Rustgi; J Alan Diehl; Constantinos Koumenis; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

7.  Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Qiujing Yu; Angelica Ortiz; Daniel P Beiting; Angela Brice; Diwakar Davar; Cindy Sanders; John M Kirkwood; Hallgeir Rui; Xiaowei Xu; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

8.  HCV infection selectively impairs type I but not type III IFN signaling.

Authors:  Partha K Chandra; Lili Bao; Kyoungsub Song; Fatma M Aboulnasr; Darren P Baker; Nathan Shores; William C Wimley; Shuanghu Liu; Curt H Hagedorn; Serge Y Fuchs; Tong Wu; Luis A Balart; Srikanta Dash
Journal:  Am J Pathol       Date:  2013-11-09       Impact factor: 4.307

9.  Jun activation domain-binding protein 1 (JAB1) is required for the optimal response to interferons.

Authors:  Ryuta Muromoto; Maiko Nakajima; Koki Hirashima; Toru Hirao; Shigeyuki Kon; Kazuya Shimoda; Kenji Oritani; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

10.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.